September 13, 2022

RTOG 3508 Interim Analysis Yields no Survival Benefit with the Addition of Depatuxizumab-Mafodotin for EGRF-amplified Newly Diagnosed Glioblastoma

Read more
August 29, 2022

RTOG Foundation STEEL Trial Exceeds Patient Accrual Goal

Read more

About RTOG Foundation

The RTOG Foundation is a nonprofit organization dedicated to improving outcomes for cancer patients through the conduct of practice changing clinical trials. RTOG collaborates with partners from industry and federally funded programs to support its research.

Read about RTOG

Participate in RTOG Research

To participate as an RTOG study investigator, your organization must be part of the RTOG Foundation network. Patients who wish to participate in a study must be under the care of an RTOG participating investigator. For additional information, email or call 1-215-574-3173.

See our clinical trials